Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02567240 · ClinicalTrials.gov registry record · Phase 1
Carbon Monoxide-Saturated Medium for Islet Isolation
A Phase 1 study of Chronic Pancreatitis, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT02567240 is a Phase 1 study of Chronic Pancreatitis that has completed, run by Medical University of South Carolina. The registered enrollment target is 16 participants, below the 689-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02567240, a Phase 1 study of Chronic Pancreatitis, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine whether harvesting islets using carbon monoxide (CO)-saturated mediums can protect islet cell from death after autologous islet transplantation in patients with chronic pancreatitis.
Conditions Studied
Interventions
- OTHER Carbon monoxide-bubbled mediums
Study Locations (1)
South Carolina
- GI Surgery, Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02567240
The ClinicalTrials.gov registry entry for NCT02567240 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 689-participant average among 42 other Chronic Pancreatitis trials with a reported enrollment target (98% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which Carbon monoxide-bubbled mediums is the first listed.
NCT02567240 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT02567240 about?
NCT02567240 is a clinical study titled "Carbon Monoxide-Saturated Medium for Islet Isolation". The goal of this study is to determine whether harvesting islets using carbon monoxide (CO)-saturated mediums can protect islet cell from death after autologous islet transplantation in patients with chronic pancreatitis.
What is the current status of trial NCT02567240?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2015-01. Estimated completion is 2018-12.
What conditions does trial NCT02567240 study?
This clinical trial studies the following conditions: Chronic Pancreatitis.
What interventions are being tested in trial NCT02567240?
The interventions under investigation include: Carbon monoxide-bubbled mediums (OTHER).
Who is sponsoring clinical trial NCT02567240?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02567240 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
RECRUITING · Phase 1
-
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
RECRUITING · Phase 1
-
Soy Tomato Juice to Improve Outcomes in Pancreatitis
RECRUITING · Phase 1
-
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
RECRUITING · Phase 1
-
Trial of Indomethacin in Chronic Pancreatitis
COMPLETED · Phase 1
-
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.